| Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders | | NCT00004767 |
| Sodium benzoate in chronic schizophrenia – an open label, add-on safety and efficacy study | In people with treatment resistant schizophrenia, is sodium benzoate a tolerated and acceptable augmentation strategy: a phase Ib/II study. | ACTRN12615000460505 |
| Sodium benzoate for treatment of attenuated psychosis | Sodium benzoate for treatment of attenuated/transient psychosis. A randomized placebo-controlled trial | EUCTR2013-000458-23-FI |
| Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate. | Comparative Randomized, Single Dose, Three-Period Crossover Open-Label Study to Determine the Bioequivalence Of Terix Labs Ltd Metronidazole Benzoate (400 mg Metronidazole Per Sachet Oral Granules (Formula A)) Relative to 500 mg From Sanofi-aventis Flagyl 125 mg/5 ml (125 mg Metronidazole Per 5 ml Suspension (Formula B)) and Zentiva Flagyl™ 400 mg Tablets (400 mg Metronidazole Per Film Coated Tablets (Formula C)) , After an Oral Administration to Healthy Adults Under Fasting Conditions | NCT02146209 |
| The Efficacy of Sodium Benzoate as an Adjunctive Treatment in Early Psychosis | The Efficacy of Sodium Benzoate as an Adjunctive Treatment in Early Psychosis | ACTRN12615000187549 |
| Study to Determine the Equivalence of Two Products Containing Metronidazole Benzoate | Comparative Randomized, Single Dose, Two-Way Crossover Open Label Bioequivalence Study of Terix Labs Ltd Metronidazole Benzoate (400 mg Metronidazole Per Sachet Oral Granules) Versus Zentiva Flagyl™ 400 mg Tablets (400 mg Metronidazole Per Film Coated Tablet), After An Oral Administration Of 400 mg to Healthy Adults Under Fasting Conditions | NCT02402283 |
| Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy | A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Two Doses of AMMONUL® (Sodium Phenylacetate and Sodium Benzoate) Injection 10% / 10% in Subjects With Grade 3 or 4 Hepatic Encephalopathy | NCT00597909 |
| Two-part Clinical Study to Evaluate the Safety and Efficacy of NaBen® in Adults with Refractory Schizophrenia | An adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, as an Add-on with Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults | EUCTR2017-001170-42-PL |
| An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2 | Local, Multicentre, Observational, Non-Interventional Prospective Study of Alogliptin Benzoate in Patients With Diabetes Mellitus Type 2 | NCT02756832 |
| Investigating the effect of aluminum hydroxide and sodium benzoate polishing powder on plaque and inflammation | Comparison of the effect of aluminum hydroxide powder and sodium benzoate on stain, plaque and inflammation | IRCT20241111063675N1 |
| A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache | A Comparison of Rimegepant Orally Disintegrating Tablet (Nurtec ODT) to Rizatriptan Benzoate Orally Disintegrating Tablet (Maxalt MLT-ODT) in Adult Patients Presenting to the ED With Migraine Headache: Randomized, Double-Blind, Clinical Trial | NCT06473597 |
| Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate | Functional Connectivity and Associated Neuropeptides Variations in Treatment Resistant Schizophrenia Patients: Treatment Efficacy of add-on Sodium Benzoate | NCT06340789 |
| Evaluation of NaBen® (sodium benzoate) in treatment of schizophrenia in adults | An Adaptive, Phase IIb/III, Multi-center, Prospective, Randomized, Double-Blind Placebo-controlled Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, as an Add-on Treatment for Schizophrenia in Adults - SNR-04 | EUCTR2017-001169-26-PL |
| Dose finding clinical trial of sodium benzoate in people with treatment refractory schizophrenia | Dose finding clinical trial of sodium benzoate in people with treatment refractory schizophrenia | ACTRN12621000327886 |
| Multi-center, randomized, double-blind, placebo/positive parallel phase III clinical trial to evaluate the efficacy and safety of fugliglitinate benzoate tablets in type 2 diabetes patients who cannot effectively control blood glucose through diet and exercise | Multi-center, randomized, double-blind, placebo/positive parallel phase III clinical trial to evaluate the efficacy and safety of fugliglitinate benzoate tablets in type 2 diabetes patients who cannot effectively control blood glucose through diet and exercise | ChiCTR2000034343 |
| Effect of the bitter taste chemical, denatonium benzoate, on metabolic control in healthy adults. | Effect of bitter taste chemical, denatonium benzoate, on glycaemia, gastrointestinal hormones, antropyloroduodenal motility and appetite in healthy adults. | ACTRN12616000026426 |
| Study of the effect of benzoic acid on glutamic acid | Effects of sodium benzoate on glutamate and glutathione levels in patients with treatment-resistant schizophrenia | JPRN-jRCTs031200050 |
| Two-part Clinical Study to Evaluate the Safety and Benefits of NaBen® in Adolescents with Schizophrenia | An Adaptive, Phase IIb/III, Double-Blind, Randomized, Placebo- Controlled, Multi-Center Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, as an Add-on Treatment for Schizophrenia in Adolescents. - SNR-01-NaBen | EUCTR2017-001168-39-PL |
| Efficacy and Safety of Sodium Benzoate in the Management of Hyperammonemia in Infants, Children and Adolescent With Chronic Liver Disease. | Efficacy and Safety of Sodium Benzoate in the Management of Hyperammonemia in Infants, Children and Adolescents With Chronic Liver Disese - A Randomised Controlled Trial. | NCT04022941 |
| Pharmacokinetics Evaluation of Fotagliptin Benzoate Tablets and Metformin Hydrochloride Tablets in Single-ues and Combination Therapy in Healthy Subjects | Fotagliptin Benzoate Tablets and Metformin Hydrochloride Tablets Pharmacokinetics Evaluation in Healthy Subjects | ChiCTR1900022104 |
| Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder. | A Multicentre 12-week Randomised Double-blind Placebo Controlled Feasibility Trial of Sodium Benzoate and/or N-acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder. | NCT03510741 |
| Role of Sodium Benzoate in the decreasing ammonia levels in children with chronic liver disease | Efficacy and safety of sodium benzoate in the management of hyperammonemia in infants, children and adoloscents with Chronic liver disese - Randomised Controlled Trial | CTRI/2017/08/009329 |
| Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules | An Open Label, Single-site Pharmaco-Scintigraphic Phase I - Study in Healthy Subjects to Evaluate the Gastrointestinal Transit and Release Profile of Radio-labelled Metronidazole Benzoate Capsules | NCT02911298 |
| Multi-center, randomized, double-blind, placebo parallel controlled phase III clinical trial for the efficacy and safety of fugliglitinate benzoate tablets in patients with type 2 diabetes who cannot be effectively controlled by metformin | Multi-center, randomized, double-blind, placebo parallel controlled phase III clinical trial for the efficacy and safety of fugliglitinate benzoate tablets in patients with type 2 diabetes who cannot be effectively controlled by metformin | ChiCTR2000033616 |
| Comparative Efficacy of Phenylbutyrate (PBA) vs. Benzoate in Urea Cycle Disorders | Comparative Efficacy of Phenylbutyrate vs. Benzoate in Urea Cycle Disorders | NCT02111200 |
